![Christophe Jean](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christophe Jean
Director/Board Member at
RHYTHM PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2026-07-30
Profile
Christophe R. Jean is on the board of Rhythm Pharmaceuticals, Inc. and European Biopharmaceutical Enterprises. In the past Mr. Jean occupied the position of EVP-Strategy & Business Development at Ipsen SA and EVP-Strategy & Business Development at Ipsen Pharma SAS (a subsidiary of Ipsen SA), Head-Europe, Middle East & Africa at Novartis AG President-Europe, Middle East & Africa at Novartis Pharmaceuticals Corp. and Financial Controller & Head-Finance at Ciba-Geigy AG (both are subsidiaries of Novartis AG), Chairman & Chief Executive Officer at Pierre Fabre Médicament SAS and Managing Director at Ipsen Pharma SA. Mr. Jean received an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-23 | 11,712 ( 0.02% ) | 1 M $ | 2026-07-30 |
Christophe Jean active positions
| Companies | Position | Start |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 2015-03-31 |
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops innovative products and breakthrough therapeutic concepts for pharma industries | Director/Board Member | - |
eureKING SA
 eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Founder | - |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Director/Board Member | - |
Back to Basics, Inc.
 Back to Basics, Inc. Food RetailRetail Trade Engages in retails sales of vitamins and supplement products | Director/Board Member | - |
Former positions of Christophe Jean
| Companies | Position | End |
|---|---|---|
| IPSEN | Chief Operating Officer | 2013-10-31 |
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Director/Board Member | 2012-12-19 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Director/Board Member | 2007-12-31 |
Pierre Fabre Group
 Pierre Fabre Group Household/Personal CareConsumer Non-Durables Manufactures cosmetics and skincare products | Corporate Officer/Principal | 2001-12-31 |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Christophe Jean
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Health Technology |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Keosys SAS
 Keosys SAS Medical/Nursing ServicesHealth Services Provides medical imaging technology and associated services | Health Services |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Health Technology |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops innovative products and breakthrough therapeutic concepts for pharma industries | Commercial Services |
Eurobio-Scientific SA
 Eurobio-Scientific SA Medical SpecialtiesHealth Technology Develops and distributes medical diagnosis tool kits | Health Technology |
Back to Basics, Inc.
Back to Basics, Inc. Food RetailRetail Trade Engages in retails sales of vitamins and supplement products | Retail Trade |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pierre Fabre Group
Pierre Fabre Group Household/Personal CareConsumer Non-Durables Manufactures cosmetics and skincare products | Consumer Non-Durables |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
- Stock Market
- Insiders
- Christophe Jean
